Home
>
National Drug Code (NDC)
>
LISINOPRIL AND HYDROCHLOROTHIAZIDE
LISINOPRIL AND HYDROCHLOROTHIAZIDE - 52125-499-20 - (LISINOPRIL AND HYDROCHLOROTHIAZIDE)
Drug Information of LISINOPRIL AND HYDROCHLOROTHIAZIDE
| Product NDC: | 52125-499 |
| Proprietary Name: | LISINOPRIL AND HYDROCHLOROTHIAZIDE |
| Non Proprietary Name: | LISINOPRIL AND HYDROCHLOROTHIAZIDE |
| Active Ingredient(s): | 12.5; 10 mg/1; mg/1 & nbsp; LISINOPRIL AND HYDROCHLOROTHIAZIDE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of LISINOPRIL AND HYDROCHLOROTHIAZIDE
| Product NDC: | 52125-499 |
| Labeler Name: | REMEDYREPACK INC. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077912 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130705 |
Package Information of LISINOPRIL AND HYDROCHLOROTHIAZIDE
| Package NDC: | 52125-499-20 |
| Package Description: | 100 TABLET in 1 VIAL (52125-499-20) |
NDC Information of LISINOPRIL AND HYDROCHLOROTHIAZIDE
| NDC Code | 52125-499-20 |
| Proprietary Name | LISINOPRIL AND HYDROCHLOROTHIAZIDE |
| Package Description | 100 TABLET in 1 VIAL (52125-499-20) |
| Product NDC | 52125-499 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | LISINOPRIL AND HYDROCHLOROTHIAZIDE |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20130705 |
| Marketing Category Name | ANDA |
| Labeler Name | REMEDYREPACK INC. |
| Substance Name | HYDROCHLOROTHIAZIDE; LISINOPRIL |
| Strength Number | 12.5; 10 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient],Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
